Association between absolute lymphocyte count and overall mortality in patients with surgically resected gastric cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Lymphocytes are an important component of the cell-mediated immune system. As lymphopenia is reportedly associated with poor prognoses in patients with various cancers, we investigated this notion in patients who underwent curative gastrectomy. Methods: We retrospectively analyzed the association between absolute lymphocyte count (ALC) and prognosis in patients with stage I–III gastric cancer who underwent curative surgical resection. Ever lymphopenic patients were defined as those with ALCs < 1,000/μL at any time post-diagnosis except within 30 days post-surgery. Adjusted multivariable regression models were used to evaluate the associations between lymphopenia and overall mortality, gastric cancer-specific mortality, and disease-free survival. Results: We investigated 1,222 patients diagnosed between January 2011 and December 2015. Fifty-six patients (4.6%) were lymphopenic at diagnosis and nearly one-quarter (24.8%) were ever lymphopenic with a mean minimum ALC of 640/ μL. Older age (odds ratio [OR], 1.02) and higher stage (stage III vs. I; OR, 3.01) were positively associated with ever lymphopenia. On multivariable analysis, ever lymphopenia predicted higher overall mortality (hazard ratio [HR], 1.83; p = 0.008), higher gastric cancer-specific mortality (HR, 1.58; p = 0.048), and shorter disease- free survival (HR, 1.83; p = 0.006). The 5-year gastric cancer-specific mortality rates for ever- and never lymphopenic patients were 10.9% and 3.7%, respectively; their 5-year cumulative recurrence rates were 15.1% and 4.6%, respectively. Conclusions: This study demonstrate that ever lymphopenia is independent prognostic factor for overall mortality and recurrence in patients with potentially curable gastric cancer; hence, ALCs may be a biomarker for predicting the prognoses of patients with stage I–III gastric cancer who had curative gastrectomy.
Abstract
Background/Aims: Lymphocytes are an important component of the cell-mediated immune system. As lymphopenia is reportedly associated with poor prognoses in patients with various cancers, we investigated this notion in patients who underwent curative gastrectomy. Methods: We retrospectively analyzed the association between absolute lymphocyte count (ALC) and prognosis in patients with stage I–III gastric cancer who underwent curative surgical resection. Ever lymphopenic patients were defined as those with ALCs < 1,000/μL at any time post-diagnosis except within 30 days post-surgery. Adjusted multivariable regression models were used to evaluate the associations between lymphopenia and overall mortality, gastric cancer-specific mortality, and disease-free survival. Results: We investigated 1,222 patients diagnosed between January 2011 and December 2015. Fifty-six patients (4.6%) were lymphopenic at diagnosis and nearly one-quarter (24.8%) were ever lymphopenic with a mean minimum ALC of 640/ μL. Older age (odds ratio [OR], 1.02) and higher stage (stage III vs. I; OR, 3.01) were positively associated with ever lymphopenia. On multivariable analysis, ever lymphopenia predicted higher overall mortality (hazard ratio [HR], 1.83; p = 0.008), higher gastric cancer-specific mortality (HR, 1.58; p = 0.048), and shorter disease- free survival (HR, 1.83; p = 0.006). The 5-year gastric cancer-specific mortality rates for ever- and never lymphopenic patients were 10.9% and 3.7%, respectively; their 5-year cumulative recurrence rates were 15.1% and 4.6%, respectively. Conclusions: This study demonstrate that ever lymphopenia is independent prognostic factor for overall mortality and recurrence in patients with potentially curable gastric cancer; hence, ALCs may be a biomarker for predicting the prognoses of patients with stage I–III gastric cancer who had curative gastrectomy.
참고문헌 (39)
- Crew KD, "Epidemiology of upper gastrointestinal malignancies", Semin Oncol, 31, pp.450~464 (2004)
- Washington K, "7th Edition of the AJCC cancer staging manual: stomach", Ann Surg Oncol, 17, pp.3077~3079 (2010)
- Siewert JR, "Relevant prognostic factors in gastric cancer : ten-year results of the German Gastric Cancer Study", Ann Surg, 228, pp.449~461 (1998)
- Campian JL, "Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer", Head Neck, 36, pp.1747~1753 (2014)
- Manuel M, "Lymphopenia combined with low TCR diversity(divpenia)predicts poor overall survival in metastatic breast cancer patients", Oncoimmunology, 1, pp.432~440 (2012)
- Vicente Conesa MA, "Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy", Breast, 21, pp.468~474 (2012)
- Ray-Coquard I, "Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas", Cancer Res, 69, pp.5383~5391 (2009)
- Balmanoukian A, "The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas", Cancer Invest, 30, pp.571~576 (2012)
- Lissoni P, "Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors", Int J Biol Markers, 19, pp.135~140 (2004)
- Bruckner HW, "Absolute granulocyte, lymphocyte, and moncyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach", JAMA, 247, pp.1004~1006 (1982)
- Eo WK, "Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer", World J Gastroenterol, 21, pp.2668~2676 (2015)
- Hu ZD, "Prognostic value of neutrophil to lymphocyte ratio for gastric cancer", Ann Transl Med, 3, pp.50~ (2015)
- Miyamoto R, "The neutrophil-to-lymphocyte ratio(NLR)predicts short-term and long-term outcomes in gastric cancer patients", Eur J Surg Oncol, 44, pp.607~612 (2018)
- Mori M, "An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer", BMC Cancer, 18, pp.1261~ (2018)
- Afghahi A, "Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer", Clin Cancer Res, 24, pp.2851~2858 (2018)
- Shorbagy SE, "Peripheral and tissue lymphocytes as predictors of pathological response in locally advanced rectal cancer post neoadjuvant chemoradiotherapy", J Cancer Ther, 8, pp.250~267 (2017)
- Lee KH, "The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer", BMC Cancer, 18, pp.938~ (2018)
- Tatara T, "Lymphopenia predicts poor prognosis in older gastric cancer patients after curative gastrectomy", Geriatr Gerontol Int, 19, pp.1215~1219 (2019)
- Japanese Gastric Cancer Association, "Japanese gastric cancer treatment guidelines 2014(ver. 4)", Gastric Cancer, 20, pp.1~19 (2017)
- d’Engremont C, "Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer : a multicentric study", BMC Cancer, 16, pp.823~ (2016)
- Szor DJ, "Prognostic role of neutrophil", lymphocyte ratio in resected gastric cancer: a systematic review and meta-analysis, 2018, pp.73, e360~
- Coussens LM, "Inflammation and cancer", Nature, 420, pp.860~867 (2002)
- Yu Q, "Prognostic role of C-reactive protein in gastric cancer : a meta-analysis", Asian Pac J Cancer Prev, 14, pp.5735~5740 (2013)
- Lee S, "Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy", BMC Cancer, 13, pp.350~ (2013)
- Powell AGMT, "Prognostic significance of serum inflammatory markers in gastric cancer", J Gastrointest Surg, 22, pp.595~605 (2018)
- Feng F, "Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer", BMC Gastroenterol, 18, pp.148~ (2018)
- Tang C, "Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes", Int J Radiat Oncol Biol Phys, 89, pp.1084~1091 (2014)
- Huang B, "TLR signaling by tumor and immune cells : a double-edged sword", Oncogene, 27, pp.218~224 (2008)
- Saito T, "Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer", Clin Cancer Res, 5, pp.1263~1273 (1999)
- Dworacki G, "Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma", Clin Cancer Res, 7, pp.947s~957s (2001)
- Goldrath AW, "Selecting and maintaining a diverse T-cell repertoire", Nature, 402, pp.255~262 (1999)
- Fridman WH, "The immune contexture in human tumours : impact on clinical outcome", Nat Rev Cancer, 12, pp.298~306 (2012)
- Naito Y, "CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer", Cancer Res, 58, pp.3491~3494 (1998)
- Britten CM, "Minimal information about T cell assays : the process of reaching the community of T cell immunologists in cancer and beyond", Cancer Immunol Immunother, 60, pp.15~22 (2011)
- Czystowska M, "The immune signature of CD8(+)CCR7(+)T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC", Clin Cancer Res, 19, pp.889~899 (2013)
- Whiteside TL, "What are regulatory T cells (Treg) regulating in cancer and why?", Semin Cancer Biol, 22, pp.327~334 (2012)
- Lee JS, "Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a systematic review and meta-analysis", Medicine (Baltimore), 97, pp.e11769~ (2018)
- Kang BW, "Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology", World J Gastrointest Oncol, 9, pp.293~299 (2017)
- Kang WM, "Factors associated with early recurrence after curative surgery for gastric cancer", World J Gastroenterol, 21, pp.5934~5940 (2015)